Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Cancer
|
Cardiovascular
|
Infection
|
Metabolic
|
Musculoskeletal
|
CNS
|
Respiratory
|
Gastrointestinal
|
Other
|
Therapy Sector Stage - Respiratory
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
Betanis, Tradjenta and Onbrez priced and set for launch in Japan
08 September 2011
Takeda resubmits alogliptin NDAs in US as cardiovascular dat...
NICE green light helps Merck offer RA patients wider treatme...
Almirall submits European MAA for COPD drug
28 July 2011
Bayer/J&J report positive Xarelto results in Japanese AF patients
26 July 2011
Focus on Almirall: partnering, new products and mature markets are key targets
26 July 2011
US FDA panel backs Remicade use for ulcerative colitis in children
22 July 2011
>> More News...
LATEST ANALYSIS
Challenges and opportunities in the Philippine pharma market
08 January 2010
Making the most of Asia's growing opportunities
17 December 2009
2010 Scrip 100 - Little change in win, place or show
09 December 2009
>> More Analysis...
LATEST FEATURES
Recipharm sees opportunity to ride wave of CDMO consolidation
17 December 2009
Xention looks to ion technology to jump start safer treatments
30 October 2009
Archimedes – a fast mover in a niche sector
19 June 2009
>> More Features...
LATEST COMMENT
Private investment round-up: December 2009
06 January 2010
The frustration of high medicine prices
04 September 2009
US agencies move forward with comparative effectiveness research plans
20 August 2009
>> More Comment...
LATEST SCIENCE
Pharmacotherapy of pneumonia occurring in older patients
12 May 2009
Inhaled corticosteroids in COPD: systemic effects of a local therapy?
12 May 2009
Assessment of individual lung cancer risk by the proteomic analysis of exhaled breath condensate
23 April 2009
>> More Science...
REFINE BY
COMPANY/ORGANISATION
GLAXOSMITHKLINE
NOVARTIS
PFIZER
ASTRAZENECA
CONDITION
ASTHMA
CANCER
DIABETES
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
GEOGRAPHY
JAPAN
CHINA
GERMANY
CANADA
DRUG
FORMOTEROL
BUDESONIDE
PALIVIZUMAB
ZANAMIVIR
